Skip to main content

Market Overview

Kindred Biosciences (NASDAQ: KIN)

4.45 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
1/26/21Aegis CapitalMaintainsBuy16.0
7/29/20Cantor FitzgeraldMaintainsOverweight11.0
3/17/20StifelMaintainsBuy13.0
3/17/20H.C. WainwrightMaintainsBuy9.0
7/16/19B. RileyDowngradesNeutral8.5
6/11/19BarclaysInitiates Coverage OnOverweight13.0
5/23/19Stifel NicolausInitiates Coverage OnBuy14.0
10/31/18Cantor FitzgeraldMaintainsOverweight25.0
8/07/18B. Riley FBRMaintainsBuy16.0
8/07/18Ladenburg ThalmannDowngradesNeutral

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter